World
Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry
- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...
October 02, 2024 | News
Thermo Fisher Scientific Expands Global Reach with Launch of CorEvitas Adolescent Atopic Dermatitis Registry
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis ...
October 01, 2024 | News
Telix Pharmaceuticals to Acquire RLS Radiopharmacies, Expanding U.S. Manufacturing Footprint and Radiometal Production Network
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS Radiopharmacies), the only Joint Commission-accredited radiopharmacy n...
September 23, 2024 | News
GE HealthCare Introduces Venue Sprint™: A Portable, Advanced Ultrasound Solution for Point-of-Care Excellence
Unveiling Venue Sprint™, the latest Venue family solution offering maximum portability and advanced capabilities for high-quality scanning an...
September 20, 2024 | News
Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®
Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...
September 18, 2024 | News
Massive Bio Launches Free AI-Powered Portal to Simplify Cancer Clinical Trial Enrollment for Patients Worldwide
Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...
September 17, 2024 | News
FDA Approves Eli Lilly's EBGLYSS™ for Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 and Over
Eli Lilly and Company (NYSE: LLY) announced the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 ...
September 16, 2024 | Analysis
SOPHiA GENETICS and AstraZeneca Expand Global Rollout of MSK-ACCESS® Liquid Biopsy Test to 20 Locations
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, announced a new milestone in t...
September 11, 2024 | News
Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...
September 05, 2024 | News
BD Expands Smart Connected Care Portfolio with Acquisition of Edwards Lifesciences’ Critical Care Product Group
Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools Com...
September 04, 2024 | News
Biocon Biologics Secures Market Access for Bmab 1200 in Europe, UK, Canada, and Japan Through Janssen Settlement
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has signed a settleme...
August 29, 2024 | News
GenScript Launches "GenTeer" Volunteer Platform, Pioneering Global Philanthropy with a Focus on ESG Impact
GenScript Biotech Corporation (referred to as GenScript) officially launched the "GenTeer (GenScript Volunteer) Program," an innovative global philanthropy...
August 21, 2024 | News
Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...
August 12, 2024 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
